ACH
DXCM icon

ArrowMark Colorado Holdings’s DexCom DXCM Stock Holding History

ArrowMark Colorado Holdings’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-919,056
Closed -$34.4M – 324
2019
Q2 		$34.4M Sell
919,056
-141,072
-13% -$4.43M 0.33% 83
2019
Q1 		$31.6M Buy
1,060,128
+7,816
+0.7% +$275K 0.3% 91
2018
Q4 		$31.5M Sell
1,052,312
-463,232
-31% -$14.7M 0.33% 92
2018
Q3 		$54.2M Sell
1,515,544
-1,480,148
-49% -$45.9M 0.45% 75
2018
Q2 		$71.1M Sell
2,995,692
-1,857,120
-38% -$39.4M 0.65% 56
2018
Q1 		$90M Buy
4,852,812
+56,600
+1% +$837K 0.9% 31
2017
Q4 		$68.8M Buy
4,796,212
+1,303,200
+37% +$16.9M 0.7% 51
2017
Q3 		$42.7M Buy
3,493,012
+990,216
+40% +$17.5M 0.49% 74
2017
Q2 		$45.8M Buy
2,502,796
+414,764
+20% +$7.66M 0.57% 64
2017
Q1 		$44.2M Sell
2,088,032
-71,524
-3% -$1.4M 0.6% 59
2016
Q4 		$32.2M Buy
2,159,556
+1,248,368
+137% +$22.1M 0.51% 66
2016
Q3 		$20M Sell
911,188
-819,756
-47% -$18.2M 0.36% 92
2016
Q2 		$34.3M Sell
1,730,944
-157,884
-8% -$2.69M 0.7% 50
2016
Q1 		$32.1M Buy
+1,888,828
New +$31.6M 0.71% 50
2015
Q3 		– Sell
-860,776
Closed -$17.2M – 284
2015
Q2 		$17.2M Sell
860,776
-170,508
-17% -$2.99M 0.42% 70
2015
Q1 		$16.1M Sell
1,031,284
-309,204
-23% -$4.67M 0.42% 78
2014
Q4 		$18.4M Sell
1,340,488
-223,972
-14% -$2.74M 0.47% 69
2014
Q3 		$15.6M Sell
1,564,460
-684,936
-30% -$7M 0.43% 76
2014
Q2 		$22.3M Buy
2,249,396
+1,096,304
+95% +$9.71M 0.64% 56
2014
Q1 		$11.9M Sell
1,153,092
-514,040
-31% -$5.31M 0.39% 102
2013
Q4 		$14.8M Buy
1,667,132
+73,468
+5% +$581K 0.46% 85
2013
Q3 		$11.2M Buy
+1,593,664
New +$10.1M 0.37% 104

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

ArrowMark Colorado Holdings's DXCM Position: Q3 2019 in Review

ArrowMark Colorado Holdings sold out of DexCom (DXCM) in Q3 2019, closing a stake of 919,056 shares — an estimated $34.4M sold.

ArrowMark Colorado Holdings first reported a position in DXCM in Q3 2013 and held it in 22 quarters. The position peaked at $90M in Q1 2018. 423 funds tracked by Wall St. Rank hold DXCM as of Q3 2019.

  • ArrowMark Colorado Holdings reported no remaining DexCom position as of Q3 2019 after selling out during the quarter.
  • ArrowMark Colorado Holdings sold 919,056 DexCom shares in Q3 2019, an estimated $34.4M.
  • ArrowMark Colorado Holdings first reported a position in DexCom in Q3 2013 and held it in 22 quarters.
  • ArrowMark Colorado Holdings's DexCom position peaked at $90M in Q1 2018.
  • 423 funds tracked by Wall St. Rank held DexCom as of Q3 2019.

Based on ArrowMark Colorado Holdings's 13F filing for Q3 2019, filed 14 Nov 2019.